Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Stack | M | 72 |
PepTx, Inc.
| - |
| Daniel T. Fagan | M | 71 |
PepTx, Inc.
| 20 years |
| Diederik Engbersen | M | - |
CimCure BV
 CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | 4 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 2 | 66.67% |
| Netherlands | 1 | 33.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Arjan W. Griffioen
- Personal Network
